Month: December 2023
New Results from Pfizer
Pfizer’s lung cancer drug Lorbrena has demonstrated groundbreaking results in clinical trials, significantly extending the lives of patients with advanced non-small cell lung cancer (NSCLC). The drug, which targets ALK-positive mutations, has shown unprecedented efficacy in preventing disease progression and…
